We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Malignant neoplasms of male genital organs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Prostate cancer is the most common cancer in men, with around 52,300 new cases diagnosed every year. Research has shown that early diagnosis has a direct link to surviving the disease, with 100% of men diagnosed at the earliest stage of prostate cancer surviving for 5 years of more. When prostate cancer is diagnosed at its’ latest stage, only ½ (49%) of all men will survive for 5 years or more.
Currently, prostate cancer is initially suspected through a check carried out by a GP and men are referred into a Hospital for further tests and imaging to confirm a diagnosis. Research also shows that many men do not know the signs and symptoms of early prostate cancer and also have a feeling of embarrassment about being screened for the disease, even if they do not have symptoms. This means that many men present with the disease late and their treatment options are limited, increasing the risk of death from the disease.
The Royal Marsden NHS Foundation Trust set-up the Man Van mobile outreach clinic in 2021. This new NHS service brings the Hospital clinical care team into the community, by targeting medium to large sized employers. The Man Van clinic aims to screen 10,500 men over the next 3 years for prostate and other male cancers as well as other diseases such as heart disease and Type II diabetes.
The routine clinical data collected from the first cohort of men (n=300) who use the Man Van clinic in its' first few months of operation, will be analysed to see how effective a mobile outreach clinic is in identifying prostate cancer earlier as well as other male cancers and other diseases.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Type: Device;
You can take part if:
You may not be able to take part if:
1. Males aged under 18 years old 2. Not participating in the Man Van mobile outreach clinic
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by THE ROYAL MARSDEN NHS FOUNDATION TRUST and funded by NHS ENGLAND .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 52619
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
